SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA issues EIR to Baddi facility of Aarti Drugs’ arm

30 Jul 2024 Evaluate

U.S. Food and Drug Administration (USFDA) has issued Establishment Inspection Report (EIR) to Aarti Drugs’ subsidiary -- Pinnacle Life Science’s manufacturing facility located at Baddi, Himachal Pradesh.

USFDA conducted inspection from April 16, 2024 to April 22, 2024. On conclusion of the inspection, the company had received 5 inspectional observations in Form 483, where none of the observations are related to Data Integrity.

Aarti Drugs is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals and also produces Formulations with its wholly-owned subsidiary - Pinnacle Life Science.

Aarti Drugs Share Price

383.40 -5.05 (-1.30%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×